USP11 has been implicated in carboplatin resistance of ovarian cancercells, through stabilization of the protein BIP. Therefore, we evaluated whether compounds 7 and 26 (alongside compound 2) could reducethe viability of platin-resistant ovarian cancer cells (PEO4). Here, USP11 is linked to ovarian carcinoma.